Evidence map›Paper›PMID 40253468›Full record

ArticleScientific reports2025

Analysis of preoperative serum cytokine levels in patients with oral squamous cell carcinoma.

Zhenying Bao, Biao Yi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhenying BaoDepartment of Clinical Laboratory Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Key Laboratory of Digital Stomatology & NMPA Key Laboratory for Dental Materials Author's, No.22 ,Zhongguancun South Avenue, Haidian District, Beijing, 100081, PR China.
Biao YiDepartment of Clinical Laboratory Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Key Laboratory of Digital Stomatology & NMPA Key Laboratory for Dental Materials Author's, No.22 ,Zhongguancun South Avenue, Haidian District, Beijing, 100081, PR China. yibiao@sina.com.

Funding

Chinese Academy of Metrology Sciences 2022YFF0710301
6 · The paper itself

Abstract

This study investigates preoperative serum cytokine levels in patients with oral squamous cell carcinoma (OSCC). The study included 51 patients with OSCC and 42 healthy controls (HCs). Serum samples of 12 cytokines were analyzed using a multiplex bead-based flow cytometry immunoassay. Mann-Whitney U test and binary logistic regression analysis were performed to identify significant indicators of OSCC. Receiver operating characteristic (ROC) curves evaluated the diagnostic performance.Spearman analysis was assessed the correlation between cytokines and tumor-node-metastasis staging of OSCC. Serum levels of interleukin (IL)-2, IL-5, IL-6, IL-8, IL-12P70, IL-17, and interferon gamma (IFN-γ) were significantly higher (P < 0.05) in patients with OSCC than in HCs. IL-5, IL-6, IL-8, IL-12P70, IL-17, IFN-γ, combination 1 (IL-6 and IL-8), and combination 2 (IL-6 and IL-12P70) had area under the curve (AUC) values > 0.7, with combination 2 exhibited the highest AUC of 0.995. Serum cytokine profiles were significantly different (P < 0.05) between the patients with OSCC and HCs. IL-5, IL-6, IL-8, IL-12P70, IL-17, IFN-γ, combination 1, and combination 2 effectively distinguished between HCs and patients with OSCC. Cytokine combinations enhanced OSCC diagnostic accuracy, with significantly elevated IL-6 levels (P < 0.05) in advanced-stage compared to early-stage OSCC, indicating its potential impact on disease progression and prognosis.

Indexed as

Carcinoma, Squamous CellCytokinesMouth NeoplasmsAdultAgedBiomarkers, TumorCase-Control StudiesFemaleHumansMaleMiddle AgedNeoplasm StagingPreoperative PeriodROC CurveBiomarkers, TumorCytokinesCytokinesInflammatoryOral squamous cell carcinomaSerum

Identifiers

PMID40253468
PMCPMC12009433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.